News & Articles

Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies

Discover the advantages of 3D-bead-beating technology for the extraction and protection of high-quality nucleic acids, in this on-demand webinar

Join us on Friday, October 30, to learn about choosing a reproducible starting point for chromatographic method development

The collaboration will focus on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy

Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days

Watch world-renowned experts and connect with leading innovators on the hottest topics, new developments and latest technologies in neuroscience

The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts

University of Connecticut (UConn) microbial ecologist Dr. Kendra Maas reveals how Ceres Nanosciences’ Nanotrap® particles have saved her invaluable time as she builds an ambitious COVID-19 tracking system

Join us Thursday, November 5, to learn how to introduce base editing technology into your cell therapy pipeline

This completely new line of separation instrumentation and software is designed for the widest range of analytes including proteins, and more

The GeneSys software now combines sample positioning and image capture on one screen, making it easier for scientists to set up and image gels and blots in fewer clicks

Exclusive interview with infectious diseases expert on the development of new assays including those for SARS-CoV-2

The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens

Learn the importance of low LoD tests and discover the most sensitive kits available, as determined by the FDA’s SARS-CoV-2 Reference Panel

Experts share novel techniques for accelerating monoclonal antibody discovery and development to bring hope to COVID-19 patients

The Leo Foundation-funded study for first time identifies Sbi as the molecule that induces rapid release of Interleukin-33

Novel column technology designed to put disease research and drug development on a more productive and efficient path

Watch this on-demand webinar to learn how to perform untargeted/semi-targeted metabolomic studies to discover novel biomarkers by mass spectrometry